A lawsuit in Pennsylvania has brought into the spotlight a common and underhanded tactic drug companies use to control trade of their expensive brand-name medications. Basically, major drug companies have been paying smaller generic manufacturers to delay their sales. When the generic companies accept the buyout, they agree to wait before releasing their generic brand …

Continue reading ‘Generic Drug Delays: Who Do Pharmaceutical Companies Care About?’ »